Iranian Experts Make Blood Sugar Testing Device with Analytical Scanning Technology
“This product is equipped with the latest blood sugar measurement technologies so that it provides error-free measurement during hand tremors, insufficient blood volume, and multiple self-tests,” said Mahvash Abyari, the managing director of the company.
“This product also has a wide hematocrit range (10 to 65 percent) to accurately measure blood sugar in all individuals, even those with special sensitivity like infants, pregnant women, smokers, etc.,” she added.
Abyari noted that the device needs no coding to prevent user error and no interference with at least 61 common drugs and compounds found in the blood, and it enjoys accurate measurement in venous, capillary and hypoxic blood sampling conditions, ability to store 880 blood sugar tests in the device's internal memory, ability to record blood sugar before or after meals, blood sugar level measurement within 5 seconds, and automatic date and time correction technology for blood sugar test.
“In this device, the results of blood sugar tests are transferred to the cell phone without any changes through the application,” she stated.
In a relevant development in January, specialists at an Iranian company succeeded in the development of a smart oxygen generator that can provide the patient’s information to the doctor remotely.
“A smart program has been used in this oxygen generator which provides the ground for communication between the patient and doctor and even the patient’s relatives so that in case of a change in the patient's condition, necessary treatment measures can be adopted,” said Sahar Saberi Manesh, a technical expert at ‘Fartak Danesh Kavir’ company.
“Also, due to the fact that the pathogens that the patients are exposed to can cause many problems for them, nano filters containing nanoparticles are used in the oxygen generator to eliminate the pathogens,” she added.
Noting that the device has been designed for home and clinic use, Saberi Manesh said, “This device has passed the clinic trial stage in one hospital and its performance has been examined by a physician, specialized in infectious diseases.”
4155/v
